Your browser doesn't support javascript.
loading
Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
Deleporte, Amélie; Van den Eynde, Marc; Forget, Frédéric; Holbrechts, Stéphane; Delaunoit, Thierry; Houbiers, Ghislain; Kalantari, Hassan R; Laurent, Stéphanie; Vanderstraeten, Erik; De Man, Marc; Vergauwe, Philippe; Clausse, Marylene; Van Der Auwera, Jacques; D'Hondt, Lionel; Pierre, Pascal; Ghillemijn, Bjorn; Covas, Angelique; Paesmans, Marianne; Ameye, Lieveke; Awada, Ahmad; Sclafani, Francesco; Hendlisz, Alain.
Affiliation
  • Deleporte A; Department of Medicine, Gastrointestinal Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Van den Eynde M; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Woluwe-St-Lambert, Belgium.
  • Forget F; Centre Hospitalier de l'Ardenne (CHA), Department of Medical Oncology, Hôpital de Libramont, Libramont-Chevigny, Belgium.
  • Holbrechts S; Department of Medical Oncology, Hôpital Ambroise Paré, Mons, Belgium.
  • Delaunoit T; Department of Medical Oncology, Hôpital de Jolimont, La Louvière, Belgium.
  • Houbiers G; Department of Gastroenterology, Clinique Saint Joseph, Liège, Belgium.
  • Kalantari HR; Department of Onco-Hematology, Centre Hospitalier Pelzer-La Tourelle (CHPLT), Verviers, Belgium.
  • Laurent S; Department of Gastroenterology, Oncology Unit, Universiteit Gent, Gent, Belgium.
  • Vanderstraeten E; Department of Medical Oncology, AZ Maria Middelares, Gent, Belgium.
  • De Man M; Department of Gastroenterology, Olv Ziekenhuis, Campus Aalst, Aalst, Belgium.
  • Vergauwe P; Department of Gastroenterology, AZ Groeninge -Kortrijk, Kortrijk, Belgium.
  • Clausse M; Department of Medicine, Oncology Unit, Clinique Saint-Luc Bouge, Namur, Belgium.
  • Van Der Auwera J; Department of Gastroenterology, AZ Monica Deurne, Deurne, Belgium.
  • D'Hondt L; Department of Medical Oncology, CHU UCL Namur - Site Godinne, Yvoir, Belgium.
  • Pierre P; Department of Medical Oncology, Hôpital d'Arlon, Arlon, Belgium.
  • Ghillemijn B; Department of Medicine, AZ Glorieux, Ronse, Belgium.
  • Covas A; Department of Medicine, Gastrointestinal Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Paesmans M; Department of Statistics, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Ameye L; Department of Statistics, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Awada A; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Sclafani F; Department of Medicine, Gastrointestinal Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Hendlisz A; Department of Medicine, Gastrointestinal Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.
Cancer Med ; 10(13): 4366-4374, 2021 07.
Article in En | MEDLINE | ID: mdl-34057299

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Type of study: Clinical_trials Limits: Aged80 Language: En Journal: Cancer Med Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Type of study: Clinical_trials Limits: Aged80 Language: En Journal: Cancer Med Year: 2021 Document type: Article Affiliation country: Country of publication: